Author(s) |
Pages | |||
---|---|---|---|---|
Editorial Board
|
IFC | |||
Editorial | ||||
Article Title | Author(s) | Pages | ||
Establishing safe and effective antithrombotic therapy use in children…..finally
|
A. Bruce, M.E. Bauman, M.P. Massicotte | 693-694 | ||
Review | ||||
Article Title | Author(s) | Pages | ||
Cerebral infarction in β-thalassemia intermedia: Breaking the silence
|
Khaled M. Musallam, Ali T. Taher, Mehran Karimi, Eliezer A. Rachmilewitz | 695-702 | ||
Original Articles | ||||
Clinical Studies | ||||
Article Title | Author(s) | Pages | ||
Detection of Thromboembolism with 99mTc-labeled F(ab)2 Fragment of Anti-glycoprotein IIIa Chimeric Monoclonal Antibody in Beagle Canines
|
Shundong Ji, Wei Fang, Ningzheng Dong, Zuoxiang He, et al. | 703-708 | ||
Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: The Safe, Simple Transitions (SST) study
|
Roger M. Mills, Richard D. Berkowitz, C.V. Damaraju, Lisa K. Jennings, et al. | 709-715 | ||
Higher soluble P-selectin is associated with chronic venous insufficiency: The San Diego Population Study
|
Locke J. Bryan, Peter W. Callas, Michael H. Criqui, Mary Cushman | 716-719 | ||
G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale
|
Elisabetta Favaretto, Michelangelo Sartori, Eleonora Conti, Cristina Legnani, et al. | 720-724 | ||
Heparin Infusion to Prevent Umbilical Venous Catheter Related Thrombosis in Neonates
|
Sevim Unal, Filiz Ekici, İbrahim İlker Cetin, Leyla Bilgin | 725-728 | ||
Activity and levels of factor XIII in a Venezuelan admixed population: association with rs5985 (Val35Leu) and STR F13A01 polymorphisms
|
Merlyn Vívenes, Dinorah Castro de Guerra, Álvaro Rodríguez-Larralde, Carmen Luisa Arocha-Piñango,et al. | 729-734 | ||
Validation of the Caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism
|
Hai-Xia Zhou, Li-Qing Peng, Yu Yan, Qun Yi, et al. | 735-740 | ||
Platelets and cell biology | ||||
Article Title | Author(s) | Pages | ||
Effect of laminar shear stress on the distribution of Weibel-Palade bodies in endothelial cells
|
Bieuwke S. Dragt, Ellen L. van Agtmaal, Bas de Laat, Jan Voorberg | 741-745 | ||
EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin
|
Kjell S. Sakariassen, Eti A. Femia, Federico M. Daray, Gian M. Podda, et al. | 746-752 | ||
Shear-induced platelet aggregation in aspirin-treated patients: Initial experience with the novel PlaCor PRT® device
|
Morten Würtz, Anne-Mette Hvas, Lise N. Wulff, Steen D. Kristensen, et al. | 753-758 | ||
Coagulation and Fibrinolysis | ||||
Article Title | Author(s) | Pages | ||
The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer
|
R. Niimi, M. Hasegawa, D.Q. Shi, A. Sudo | 759-764 | ||
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
|
Svein Solheim, Ingebjørg Seljeflot, Ketil Lunde, Vibeke Bratseth, et al. | 765-768 | ||
Sustained heparin effect contributes to reduced plasma thrombin generation capacity early after cardiac surgery
|
Vladimir Radulovic, Monica Hyllner, Lisa Ternström, Martin Karlsson,et al. | 769-774 | ||
The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters
|
Laura Green, Andrew S. Lawrie, Rahul Patel, Robert C.M. Stephens, et al. | 775-779 | ||
Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway
|
Laura Green, Omid Safa, Samuel J. Machin, Ian J. Mackie, et al. | 780-784 | ||
Novel management of anticoagulant resistant thrombotic hypodysfibrinogenaemia
|
C. Rea, B.J. Hunt | 785-787 | ||
Bridging with the Low molecular weight heparin certoparin in patients requiring temporary discontinuation of oral anticoagulation – the non-interventional, retrospective REMEMBER study
|
Ralf Eisele, Nima Melzer, Cornelia Englert, Peter Bramlage, et al. | 788-792 | ||
Effect of the Factor Xa Inhibitor Rivaroxaban on Arterial Thrombosis in Wild-Type and Apolipoprotein E-Deficient Mice
|
Nana-Maria Wagner, Tobias Dressel, Katrin Schäfer, Stavros Konstantinides | 793-798 | ||
Thrombin generation post elective caesarean section: Effect of low molecular weight heparin
|
Siti K. Ismail, Lucy Norris, Shanthi Muttukrishna, John R. Higgins | 799-803 | ||
The in vitro anticoagulant effect of rivaroxaban in children
|
C. Attard, P. Monagle, D. Kubitza, V. Ignjatovic | 804-807 | ||
Functional characteristics of the novel, human-derived recombinant FVIII protein product, human-cl rhFVIII
|
Helena Sandberg, Christoph Kannicht, Peter Stenlund, Marina Dadaian, et al. | 808-817 | ||
Brief Communication | ||||
Article Title | Author(s) | Pages | ||
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: A pooled analysis
|
Bengt I. Eriksson, Ola E. Dahl, Martin Feuring, Andreas Clemens, et al. | 818-820 | ||
Letters to the Editors-in-Chief | ||||
Article Title | Author(s) | Pages | ||
Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy
|
Thein H. Oo | 821-822 | ||
LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
|
Marit S. Nenseter, Martin P. Bogsrud, Asgeir Græsdal, Ingunn Narverud,et al. | 823-825 | ||
Ante- and postpartum redox status of blood in women with inherited thrombophilia treated with heparin
|
Jelena Bogdanović Pristov, Dragana Maglić, Miloš Opačić, Vesna Mandić, et al. | 826-829 | ||
E-only Articles | ||||
Clinical Studies | ||||
Article Title | Author(s) | Pages | ||
Characterization of the hypercoagulable state in patients with sickle cell disease
|
Nirmish Shah, Courtney Thornburg, Marilyn J. Telen, Thomas L. Ortel | e241-e245 | ||
Inflammatory, immune and lipid transportation proteins are differentially expressed in spontaneous and proximal deep vein thrombosis patients
|
Mariane C. Flores-Nascimento, Adriana F. Paes-Leme, Bruna M. Mazetto, Jaqueline L. Zanella, et al. | e246-e250 | ||
Platelets and cell biology | ||||
Article Title | Author(s) | Pages | ||
Bleeding diathesis in Noonan syndrome: Is acquired von Willebrand syndrome the clue?
|
Gesa Wiegand, Michael Hofbeck, Martin Zenker, Ulrich Budde, et al. | e251-e254 | ||
Thrombosis in VonWillebrand disease
|
Waqas Qureshi, Syed Hassan, Vrushali Dabak, Philip Kuriakose | e255-e258 | ||
Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus
|
Parimala Narne, Kamakshi Chaithri Ponnaluri, Shailender Singh, Mohammed Siraj, et al. | e259-e265 | ||
Coagulation and Fibrinolysis | ||||
Article Title | Author(s) | Pages | ||
Human hepatoma cell line HuH-7 is an effective cellular system to produce recombinant factor IX with improved post-translational modifications
|
Nathalie Enjolras, Yesim Dargaud, Eloïse Pérot, Florine Guillaume, et al. | e266-e273 | ||
Evaluation of the Stratus® CS Acute Care™ D-dimer assay (DDMR) using the Stratus® CS STAT Fluorometric Analyzer: A prospective multisite study for exclusion of pulmonary embolism and deep vein thrombosis
|
Robert C. Gosselin, Jogin R. Wu, Kandice Kottke-Marchant, Dirk Peetz, et al. | e274-e278 |